Levosimendan shows respiratory benefits in patients with ALS
Channel: Research Square
Date: 18/07/2019

Read the article: http://dx.doi.org/10.1136/jnnp-2018-320288

Al-Chalabi et al. "Oral Levosimendan in amyotrophic lateral sclerosis: a phase 2 multicentre, randomised, double-blind, placebo-controlled trial." Journal of Neurology, Neurosurgery and Psychiatry (2019).

Video produced by https://www.researchsquare.com